ReviewAnnals of oncology : official journal of the European Society for Medical Oncology2016

Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes.

R S Komrokji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.